Literature DB >> 7929147

Structural requirements for phosphorylation of myosin regulatory light chain from smooth muscle.

G Zhi1, B P Herring, J T Stull.   

Abstract

Site-directed and chimeric mutations of myosin regulatory light chains were used to identify residues important for phosphorylation of Ser19 by smooth muscle myosin light chain kinase. Arg16 and hydrophobic residues C-terminal of Ser19 in smooth muscle light chain were important substrate determinants in the intact protein. However, changes in the kinetic properties with mutations in the light chain were substantially smaller than results reported with structurally similar synthetic peptide substrates. These results together with the low Vmax value for short peptide substrates containing the consensus phosphorylation sequence suggest that there may be additional sites of interactions between the kinase and protein substrate. Chimeras of skeletal and smooth muscle light chains were constructed with exchanges at the N terminus and subdomains I, II, III, and IV. Analysis of results obtained on the kinetic properties for phosphorylation showed that subdomains I and II contribute to high Vmax values. Thus, a region distant from the consensus phosphorylation sequence in smooth muscle light chain is also an important substrate determinant for myosin light chain kinase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929147

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle.

Authors:  James T Stull; Kristine E Kamm; Rene Vandenboom
Journal:  Arch Biochem Biophys       Date:  2011-02-01       Impact factor: 4.013

Review 2.  Myosin light chain kinases.

Authors:  P J Gallagher; B P Herring; J T Stull
Journal:  J Muscle Res Cell Motil       Date:  1997-02       Impact factor: 2.698

3.  Cardiac myosin light chain is phosphorylated by Ca2+/calmodulin-dependent and -independent kinase activities.

Authors:  Audrey N Chang; Pravin Mahajan; Stefan Knapp; Hannah Barton; H Lee Sweeney; Kristine E Kamm; James T Stull
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

4.  Activation of Dictyostelium myosin light chain kinase A by phosphorylation of Thr166.

Authors:  J L Smith; L A Silveira; J A Spudich
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

5.  Myosin light chain kinase steady-state kinetics: comparison of smooth muscle myosin II and nonmuscle myosin IIB as substrates.

Authors:  Diego B Alcala; Brian D Haldeman; Richard K Brizendine; Agata K Krenc; Josh E Baker; Ronald S Rock; Christine R Cremo
Journal:  Cell Biochem Funct       Date:  2016-08-16       Impact factor: 3.685

6.  Identification of cardiac-specific myosin light chain kinase.

Authors:  Jason Y Chan; Morihiko Takeda; Laura E Briggs; Megan L Graham; Jonathan T Lu; Nobuo Horikoshi; Ellen O Weinberg; Hiroki Aoki; Naruki Sato; Kenneth R Chien; Hideko Kasahara
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

7.  Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy.

Authors:  Jian Huang; John M Shelton; James A Richardson; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

8.  S100A1 transgenic treatment of acute heart failure causes proteomic changes in rats.

Authors:  Yichen Guo; Lianqun Cui; Shiliang Jiang; Dongmei Wang; Shu Jiang; Chen Xie; Yanping Jia
Journal:  Mol Med Rep       Date:  2016-06-23       Impact factor: 2.952

9.  Cardiac myosin regulatory light chain kinase modulates cardiac contractility by phosphorylating both myosin regulatory light chain and troponin I.

Authors:  Ivanka R Sevrieva; Birgit Brandmeier; Saraswathi Ponnam; Mathias Gautel; Malcolm Irving; Kenneth S Campbell; Yin-Biao Sun; Thomas Kampourakis
Journal:  J Biol Chem       Date:  2020-02-21       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.